Alpha AI알파AI
043100 · KOSDAQ · ₩043100 · 알파AI
- Market cap
- ₩10B
- Enterprise value
- ₩42B
- P/E
- —
- P/B
- 0.4×
- Dividend yield
- 0.0%
- ROE
- −31.0%
- Net margin
- −70.4%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−80.0% from the high
₩494Today: ₩520 – ₩520₩2,595
Returns
- 1W0.0%
- 1M0.0%
- 3M0.0%
- 6M0.0%
- YTD−69.3%
- 1Y−76.6%
- Volume today
- —
- Traded today
- —
- Listed shares
- 20,110,080
- EPS (12 months)
- −₩409
- Earnings yield −78.6%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 43 of 100 (50 is a normal day for this stock).
- MomentumFlat0% over the last month; the price is below its 20-day average.
- News impactHigh4 news items and filings in two weeks; 1 rated high impact, 2 medium.
Signals describe activity, not recommendations. Not financial advice.
Alpha AI stock overview
Alpha AI (알파AI, KRX: 043100) is listed on KOSDAQ, in the Medical & precision devices sector. The company manufactures and sells medical products, mainly metal implants used in joint, spine and bone treatment, such as spinal systems, trauma systems and knee joints, along with a wide range of surgical instruments sold to hospitals. Its shares closed at ₩520 on Oct 28, 2026, unchanged on the day, giving it a market value of ₩10B.
Key facts
- Market cap
- ₩10B
- Sector
- Medical & precision devices
- Latest price change
- 0.00%
- As of
- Oct 28, 2026
- Main business
- The company manufactures and sells medical products, mainly metal implants used in joint, spine and bone treatment, such as spinal systems, trauma systems and knee joints, along with a wide range of surgical instruments sold to hospitals.
Quick answers about Alpha AI
- What does Alpha AI do?
- The company manufactures and sells medical products, mainly metal implants used in joint, spine and bone treatment, such as spinal systems, trauma systems and knee joints, along with a wide range of surgical instruments sold to hospitals. It also previously ran a healthcare segment selling heated mattresses and health products, which stopped operations in September 2025, and has begun real estate-related business. Its products are sold domestically and exported to markets including the United States, Japan, Europe, the Middle East and South America.
- What is the market cap of Alpha AI?
- The market capitalisation of Alpha AI was ₩10B at the close on Oct 28, 2026.
- Who are the largest shareholders of Alpha AI?
- According to the latest official filings, the largest reported holders are Ungchon Gokcheon Cooperative (15.84%, as of Oct 22, 2025); AI (AI) Innovation Growth Equity Partnership (14.94%, as of Sep 11, 2025); Eimo (13.68%, as of Sep 29, 2025).
- When is the next earnings report from Alpha AI?
- Korean companies rarely announce results dates in advance. Based on when Alpha AI filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Company profile
The company manufactures and sells medical products, mainly metal implants used in joint, spine and bone treatment, such as spinal systems, trauma systems and knee joints, along with a wide range of surgical instruments sold to hospitals. It also previously ran a healthcare segment selling heated mattresses and health products, which stopped operations in September 2025, and has begun real estate-related business. Its products are sold domestically and exported to markets including the United States, Japan, Europe, the Middle East and South America.
Written by AI from the company's latest annual report.
- Korean name
- 알파AI
- Themes
- AI software & services
- CEO
- 문성민
- Founded
- Jul 1995
- Listed
- Aug 2000
- Listed shares
- 20,110,080
- Fiscal year ends
- Month 12
- Website
- www.solco.co.kr
Similar companies
- TSE131290 · ₩3T₩275,000+5.77%
- Kctech281820 · ₩1.9T₩95,500+3.92%
- Classys214150 · ₩1.8T₩27,000+1.89%
- Park Systems140860 · ₩1.6T₩229,500+1.77%
- DI003160 · ₩1.2T₩43,300+14.55%
- LivsMed491000 · ₩1.1T₩43,650+17.65%
- Curiox Biosystems445680 · ₩1.1T₩62,400+0.16%
- Seers458870 · ₩943B₩24,600−6.46%
Recent filings
See all- Other Market Notice (Notice on Deadline for Decision on Substantive Review of Listing Eligibility)Oct 22, 2026
- Trading haltOct 21, 2026
- Other Market Notice (Notice Regarding Substantive Review of Listing Eligibility)Oct 21, 2026
- Designation as Unfaithful Disclosure Company (3 Disclosure Reversals)Oct 21, 2026
- [Corrected] Notice of Designation as Unfaithful Disclosure Entity (3 Disclosure Reversals)Oct 14, 2026
Titles in Korean until English translations are added.
Also known as: Alpha AI / 알파AI / 043100 / KRX:043100
Source: KRX statistical information